Agilent Life Sciences Unit Orders, Revenue Up 10 Percent in Fiscal Q4 | GenomeWeb

NEW YORK, Nov. 11 (GenomeWeb News) - Agilent Technology's life sciences and chemical analysis unit, which sells the company's genomics and proteomics product lines, had revenue growth of 10 percent for the quarter ending Oct. 31, the company reported today.

"LSCA shows few signs of slowing from its recent double-digit growth trend," the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.